keyword
https://read.qxmd.com/read/17952111/erythropoietin-protects-the-human-myocardium-against-hypoxia-reoxygenation-injury-via-phosphatidylinositol-3-kinase-and-erk1-2-activation
#41
JOURNAL ARTICLE
N R Mudalagiri, M M Mocanu, C Di Salvo, S Kolvekar, M Hayward, J Yap, B Keogh, D M Yellon
BACKGROUND AND PURPOSES: Erythropoietin (EPO) has been shown to protect against myocardial infarction in animal studies by activating phosphatidylinositol-3 kinase (PI3K)/Akt and ERK1/2. However these pro-survival pathways are impaired in the diabetic heart. We investigated the ability of EPO to protect human atrial trabeculae from non-diabetic and diabetic patients undergoing coronary artery bypass surgery, against hypoxia-reoxygenation injury. EXPERIMENTAL APPROACH: Human atrial trabeculae were exposed to 90min hypoxia and 120min reoxygenation...
January 2008: British Journal of Pharmacology
https://read.qxmd.com/read/17825079/preconditioning-and-postconditioning-new-strategies-for-cardioprotection
#42
REVIEW
D J Hausenloy, D M Yellon
Despite optimal therapy, the morbidity and mortality of coronary heart disease (CHD) remains significant, particularly in patients with diabetes or the metabolic syndrome. New strategies for cardioprotection are therefore required to improve the clinical outcomes in patients with CHD. Ischaemic preconditioning (IPC) as a cardioprotective strategy has not fulfilled it clinical potential, primarily because of the need to intervene before the index ischaemic event, which is impossible to predict in patients presenting with an acute myocardial infarction (AMI)...
June 2008: Diabetes, Obesity & Metabolism
https://read.qxmd.com/read/17541736/myocardial-ischaemia-reperfusion-injury-is-attenuated-by-intact-glucagon-like-peptide-1-glp-1-in-the-in-vitro-rat-heart-and-may-involve-the-p70s6k-pathway
#43
JOURNAL ARTICLE
Amal K Bose, Mihaela M Mocanu, Richard D Carr, Derek M Yellon
BACKGROUND AND METHODS: Glucagon Like Peptide-1 (GLP-1), one of the most potent incretin hormones, has potential beneficial actions on the ischaemic and failing heart. This study sought to further identify the mechanisms of action of GLP-1 on the ischaemic heart using an in vitro isolated perfused rat heart model of ischaemic-reperfusion injury (measuring infarct size to area of risk (%)) subjected to 35 min regional ischaemia and 2 h reperfusion. To examine the effect of intact GLP-1 we used an inhibitor of GLP-1 breakdown, Valine pyrrolidide (VP)...
August 2007: Cardiovascular Drugs and Therapy
https://read.qxmd.com/read/17512507/preconditioning-and-postconditioning-the-essential-role-of-the-mitochondrial-permeability-transition-pore
#44
JOURNAL ARTICLE
Shiang Y Lim, Sean M Davidson, Derek J Hausenloy, Derek M Yellon
OBJECTIVE: The opening of the mitochondrial permeability transition pore (mPTP) at the time of myocardial reperfusion is a critical determinant of cell death. Emerging studies suggest that suppression of mPTP opening may underlie the cardioprotection elicited by both ischemic preconditioning (IPC) and postconditioning (IPost). To further evaluate the role of the mPTP in cardioprotection, we hypothesized that hearts deficient in cyclophilin-D (CYP-D-/-), a key component of the mPTP, will be resistant to cardioprotection conferred by ischemic and pharmacological preconditioning and postconditioning...
August 1, 2007: Cardiovascular Research
https://read.qxmd.com/read/17443199/elevated-total-peripheral-leukocyte-count-may-identify-risk-for-neurological-disability-in-asphyxiated-term-neonates
#45
JOURNAL ARTICLE
A A Morkos, A O Hopper, D D Deming, S M Yellon, N Wycliffe, S Ashwal, L C Sowers, R L Peverini, D M Angeles
OBJECTIVE: The present study investigated the relationship between neurologic outcome and total circulating white blood cell (WBC) and absolute neutrophil counts (ANCs) in the first week of life in term infants with hypoxic-ischemic encephalopathy (HIE). STUDY DESIGN: Long-term neurologic outcome at 18 months was measured retrospectively in 30 term neonates with HIE using the Pediatric Cerebral Performance Category Scale (PCPCS) score with outcomes dichotomized as either good or poor...
June 2007: Journal of Perinatology: Official Journal of the California Perinatal Association
https://read.qxmd.com/read/17293884/pten-the-achilles-heel-of-myocardial-ischaemia-reperfusion-injury
#46
REVIEW
M M Mocanu, D M Yellon
Myocardial ischaemia/reperfusion injury leading to myocardial infarction is one of the most frequent causes of debilitation and death in man. Considerable research has been undertaken to investigate the possibility of reducing myocardial infarction and increasing cell survival by activating certain endogenous prosurvival signaling pathways. Thus, it has been established that the activation of the PI3K (Phosphoinositide-3 kinase)/Akt (Protein kinase B, PKB) signaling pathway is essential for protection against ischaemia/reperfusion injury...
April 2007: British Journal of Pharmacology
https://read.qxmd.com/read/16847434/leptin-the-obesity-associated-hormone-exhibits-direct-cardioprotective-effects
#47
JOURNAL ARTICLE
C C T Smith, M M Mocanu, S M Davidson, A M Wynne, J C Simpkin, D M Yellon
BACKGROUND AND PURPOSE: Protection against ischaemia-reperfusion (I/R) injury involves PI3K-Akt and p44/42 MAPK activation. Leptin which regulates appetite and energy balance also promotes myocyte proliferation via PI3K-Akt and p44/42 MAPK activation. We, therefore, hypothesized that leptin may also exhibit cardioprotective activity. EXPERIMENTAL APPROACH: The influence of leptin on I/R injury was examined in perfused hearts from C57Bl/6 J mice that underwent 35 min global ischaemia and 35 min reperfusion, infarct size being assessed by triphenyltetrazolium chloride staining...
September 2006: British Journal of Pharmacology
https://read.qxmd.com/read/16155408/representational-difference-analysis-of-cdna-identifies-novel-genes-expressed-following-preconditioning-of-the-heart
#48
JOURNAL ARTICLE
M A C Fauchon, T J Pell, G F Baxter, D M Yellon, D S Latchman, M F Hubank, L V Mayne
Preconditioning of the myocardium rapidly induces a number of transcription factors, which are likely to be responsible for a cascade of transcriptional changes underlying the development of delayed adaptation. Identifying these changes provides insight into the molecular pathways elicited by sub-lethal ischaemia and the mechanism leading to delayed adaptation. Genes up-regulated in rabbit myocardium in vivo by ischaemic preconditioning following reperfusion for 2 h, 4 h and 6 h post-treatment were identified by representational difference analysis of cDNA (cDNA...
August 31, 2005: Experimental & Molecular Medicine
https://read.qxmd.com/read/16046302/preconditioning-the-diabetic-heart-the-importance-of-akt-phosphorylation
#49
JOURNAL ARTICLE
Andrew Tsang, Derek J Hausenloy, Mihaela M Mocanu, Richard D Carr, Derek M Yellon
Conflicting evidence exists whether diabetic myocardium can be protected by ischemic preconditioning (IPC). The phosphatidylinositol 3-kinase (PI3K)-Akt pathway is important in IPC. However, components of this cascade have been found to be defective in diabetes. We hypothesize that IPC in diabetic hearts depends on intact signaling through the PI3K-Akt pathway to reduce myocardial injury. Isolated perfused Wistar (normal) and Goto-Kakizaki (diabetic) rat hearts were subjected to 1) 35 min of regional ischemia and 120 min of reperfusion with infarct size determined; 2) preconditioning (IPC) using 5 min of global ischemia followed by 10 min of reperfusion performed one, two, or three times before prolonged ischemia; or 3) determination of Akt phosphorylation after stabilization or after one and three cycles of IPC...
August 2005: Diabetes
https://read.qxmd.com/read/15944807/erythropoietin-protects-the-myocardium-against-reperfusion-injury-in-vitro-and-in-vivo
#50
JOURNAL ARTICLE
A J Bullard, P Govewalla, D M Yellon
OBJECTIVE: Erythropoietin (EPO) is a hormone that is currently used to treat patients with renal failure and anaemia. However, it has also been shown to protect against ischaemia/reperfusion injury; this protection occurring via activation of the ERK 1/2 and PI3K pathways. Since we have previously shown activation of ERK 1/2 and PI3K to be important for protection against reperfusion-induced injury in the myocardium, this study was designed to investigate its effect in the myocardium using both an isolated perfused rat heart and an in vivo rat recovery model of ischaemia-reperfusion...
September 2005: Basic Research in Cardiology
https://read.qxmd.com/read/15895311/protecting-the-myocardium-at-time-of-reperfusion-meeting-report-of-the-hatter-institute-4th-international-workshop-on-cardio-protection
#51
JOURNAL ARTICLE
D J Hausenloy, D M Yellon
No abstract text is available yet for this article.
July 2005: Basic Research in Cardiology
https://read.qxmd.com/read/15883751/glucagon-like-peptide-1-is-protective-against-myocardial-ischemia-reperfusion-injury-when-given-either-as-a-preconditioning-mimetic-or-at-reperfusion-in-an-isolated-rat-heart-model
#52
JOURNAL ARTICLE
Amal K Bose, Mihaela M Mocanu, Richard D Carr, Derek M Yellon
No abstract text is available yet for this article.
January 2005: Cardiovascular Drugs and Therapy
https://read.qxmd.com/read/15616022/glucagon-like-peptide-1-can-directly-protect-the-heart-against-ischemia-reperfusion-injury
#53
JOURNAL ARTICLE
Amal K Bose, Mihaela M Mocanu, Richard D Carr, Christian L Brand, Derek M Yellon
Glucagon-like peptide 1 (GLP-1), a gut incretin hormone that stimulates insulin secretion, also activates antiapoptotic signaling pathways such as phosphoinositide 3-kinase and mitogen-activated protein kinase in pancreatic and insulinoma cells. Since these kinases have been shown to protect against myocardial injury, we hypothesized that GLP-1 could directly protect the heart against such injury via these prosurvival signaling pathways. Both isolated perfused rat heart and whole animal models of ischemia/reperfusion were used, with infarct size measured as the end point of injury...
January 2005: Diabetes
https://read.qxmd.com/read/15162074/omapatrilat-limits-infarct-size-and-lowers-the-threshold-for-induction-of-myocardial-preconditioning-through-a-bradykinin-receptor-mediated-mechanism
#54
JOURNAL ARTICLE
Z Ebrahim, G F Baxter, D M Yellon
Bradykinin is an important endogenous trigger of myocardial ischemic preconditioning (IPC). Through simultaneous inhibition of neutral endopeptidase and angiotensin converting enzyme, omapatrilat prevents enzymatic degradation of bradykinin. The aim of this study was to investigate if omapatrilat, through its ability to augment bradykinin levels, can augment a subthreshold IPC stimulus (Sub-IPC) and to compare the action of omapatrilat with the angiotensin-converting enzyme inhibitor, captopril. Langendorff perfused rat hearts were subjected to 35 min left coronary artery occlusion and 120 min reperfusion...
March 2004: Cardiovascular Drugs and Therapy
https://read.qxmd.com/read/13130436/melatonin-production-accompanies-arousal-from-daily-torpor-in-siberian-hamsters
#55
COMPARATIVE STUDY
Jennie E Larkin, Steven M Yellon, Irving Zucker
Arousal from deep hibernation is accompanied by a transient rise of melatonin (Mel) in circulation; there are no comparable analyses of Mel concentrations in species that undergo much shallower, shorter duration episodes of daily torpor. Serum Mel concentrations were determined during arousal from both natural daily torpor and torpor induced by 2-deoxy-D-glucose (2-DG) treatment (2,500 mg/kg, intraperitoneal [IP]); blood samples were drawn from the retro-orbital sinus of anesthetized Siberian hamsters. For animals kept in darkness during torpor, Mel concentrations were highest during early arousal when thermogenesis is maximal, and they decreased as body temperature increased during arousal and returned to baseline once euthermia was reestablished...
July 2003: Physiological and Biochemical Zoology: PBZ
https://read.qxmd.com/read/12562504/suppression-of-hypothalamic-pro-opiomelanocortin-pomc-gene-expression-by-daily-melatonin-supplementation-in-aging-rats
#56
JOURNAL ARTICLE
Dennis D Rasmussen, Brett T Marck, Brian M Boldt, Steven M Yellon, Alvin M Matsumoto
Both plasma melatonin levels and hypothalamic arcuate nucleus pro-opiomelanocortin (POMC) (biosynthetic precursor to the endogenous opioid ss-endorphin and other opiomelanocortins) mRNA content decrease with aging. To test whether the decline in melatonin is responsible for the decline in POMC mRNA, we investigated the effects of daily melatonin treatment on hypothalamic POMC mRNA content in middle-aged and older Sprague-Dawley rats. Daily nocturnal melatonin treatment (50 microg kg bw(-1) night(-1), in the night-time drinking water) for 7 months, starting at 13 months of age, did not significantly alter female arcuate nucleus POMC mRNA content determined at the end of the light period (i...
March 2003: Journal of Pineal Research
https://read.qxmd.com/read/12234780/adenosine-a-3-receptor-activation-protects-the-myocardium-from-reperfusion-reoxygenation-injury
#57
JOURNAL ARTICLE
Helen L Maddock, Mihaela M Mocanu, Derek M Yellon
Ischemia-reperfusion induces both necrotic and apoptotic cell death. The ability of adenosine to attenuate reperfusion-induced injury (RI) and the role played by adenosine receptors are unclear. We therefore studied the role of the A(3) receptor (A(3)R) in ameliorating RI using the specific A(3)R agonist 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxi-N-methyl-b-D-ribofuranuronamide (2-Cl-IB-MECA). Isolated rat hearts and cardiomyocytes were subjected to ischemia or simulated ischemia, followed by reperfusion/reoxygenation...
October 2002: American Journal of Physiology. Heart and Circulatory Physiology
https://read.qxmd.com/read/12044434/a-comparison-between-ischemic-preconditioning-intermittent-cross-clamp-fibrillation-and-cold-crystalloid-cardioplegia-for-myocardial-protection-during-coronary-artery-bypass-graft-surgery
#58
RANDOMIZED CONTROLLED TRIAL
L K K Teoh, R Grant, J A Hulf, W B Pugsley, D M Yellon
The aim of this study was to compare ischemic preconditioning (IPC) with two established methods of myocardial protection, namely cold crystalloid cardioplegia and intermittent cross-clamp fibrillation (ICCF), in coronary artery bypass graft (CABG) surgery. This was a prospective randomised study. Thirty CABG patients were randomised to receive: (a) St Thomas' cardioplegia solution no. 2; (b) ICCF; or (c) IPC (two 3-min periods of ischemia with 2-min of reperfusion). Surgery was performed under standardised conditions by one surgeon (WBP)...
June 2002: Cardiovascular Surgery: Official Journal of the International Society for Cardiovascular Surgery
https://read.qxmd.com/read/11904451/short-day-lengths-augment-stress-induced-leukocyte-trafficking-and-stress-induced-enhancement-of-skin-immune-function
#59
JOURNAL ARTICLE
Staci D Bilbo, Firdaus S Dhabhar, Kavitha Viswanathan, Alison Saul, Steven M Yellon, Randy J Nelson
Environmental conditions influence the onset and severity of infection and disease. Stressful conditions during winter may weaken immune function and further compromise survival by means of hypothermia, starvation, or shock. To test the hypothesis that animals may use photoperiod to anticipate the onset of seasonal stressors and adjust immune function, we evaluated glucocorticoids and the distribution of blood leukocytes in Siberian hamsters (Phodopus sungorus) exposed to long day lengths (i.e., summer) or short day (SD) lengths (i...
March 19, 2002: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/11744026/the-effect-of-preconditioning-ischemic-and-pharmacological-on-myocardial-necrosis-following-coronary-artery-bypass-graft-surgery
#60
RANDOMIZED CONTROLLED TRIAL
L K K Teoh, R Grant, J A Hulf, W B Pugsley, D M Yellon
OBJECTIVES: Ischemic preconditioning is known to protect the human heart from ischemic injury during coronary artery bypass graft (CABG) surgery but is not practised routinely. Adenosine A1 receptor agonists may confer protection in this setting by mimicking preconditioning. The aim of this study was to compare preconditioning, by ischemia or an adenosine A1 receptor agonist (GR79236X), with an established method of myocardial protection in CABG, namely intermittent cross-clamp fibrillation...
January 2002: Cardiovascular Research
keyword
keyword
107712
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.